# Hess Midstream LP: financial statements, quarterly

HESM · NYSE · CIK 1789832 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hesm.md) · [Financials](/companies/hesm/financials.md) · [Filings](/companies/hesm/filings.md) · [Insiders](/companies/hesm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hesm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [363](/filings/0000950170-24-122324.md) | [357 d](/filings/0001193125-26-071592.md) | [356](/filings/0000950170-25-066990.md) | [366](/filings/0000950170-25-104058.md) | [379](/filings/0001193125-25-269594.md) | [396 d](/filings/0001193125-26-071592.md) | [382](/filings/0001193125-26-211991.md) | [414](/filings/0001193125-26-338055.md) | [421](/filings/0001193125-25-269594.md) | [404 d](/filings/0001193125-26-071592.md) | [390](/filings/0001193125-26-211991.md) | [399](/filings/0001193125-26-338055.md) |
| Operating income | $m | [220](/filings/0000950170-24-122324.md) | [210 d](/filings/0001193125-26-071592.md) | [222](/filings/0000950170-25-066990.md) | [222](/filings/0000950170-25-104058.md) | [232](/filings/0001193125-25-269594.md) | [243 d](/filings/0001193125-26-071592.md) | [237](/filings/0001193125-26-211991.md) | [260](/filings/0001193125-26-338055.md) | [259](/filings/0001193125-25-269594.md) | [252 d](/filings/0001193125-26-071592.md) | [238](/filings/0001193125-26-211991.md) | [253](/filings/0001193125-26-338055.md) |
| Income tax | $m | [11.4](/filings/0000950170-24-122324.md) | [11.9 d](/filings/0001193125-26-071592.md) | [14.3](/filings/0000950170-25-066990.md) | [16.0](/filings/0000950170-25-104058.md) | [18.9](/filings/0001193125-25-269594.md) | [22.6 d](/filings/0001193125-26-071592.md) | [23.0](/filings/0001193125-26-211991.md) | [29.1](/filings/0001193125-26-338055.md) | [31.5](/filings/0001193125-25-269594.md) | [30.2 d](/filings/0001193125-26-071592.md) | [28.2](/filings/0001193125-26-211991.md) | [31.1](/filings/0001193125-26-338055.md) |
| Net income | $m | [35.3](/filings/0000950170-24-122324.md) | [37.5 d](/filings/0001193125-26-071592.md) | [44.6](/filings/0000950170-25-066990.md) | [49.5](/filings/0000950170-25-104058.md) | [58.6](/filings/0001193125-25-269594.md) | [70.4 d](/filings/0001193125-26-071592.md) | [71.6](/filings/0001193125-26-211991.md) | [90.3](/filings/0001193125-26-338055.md) | [97.7](/filings/0001193125-25-269594.md) | [93.3 d](/filings/0001193125-26-071592.md) | [87.6](/filings/0001193125-26-211991.md) | [96.4](/filings/0001193125-26-338055.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0000950170-23-058224.md) | [5.4](/filings/0000950170-25-029068.md) | [4.2](/filings/0000950170-24-054507.md) | [99.6](/filings/0000950170-24-094014.md) | [10.3](/filings/0000950170-24-122324.md) | [4.3](/filings/0001193125-26-071592.md) | [6.1](/filings/0000950170-25-066990.md) | [4.5](/filings/0000950170-25-104058.md) | [5.5](/filings/0001193125-25-269594.md) | [1.9](/filings/0001193125-26-338055.md) | [4.6](/filings/0001193125-26-211991.md) | [5.0](/filings/0001193125-26-338055.md) |
| Current assets | $m | [138](/filings/0000950170-23-058224.md) | [137](/filings/0000950170-25-029068.md) | [139](/filings/0000950170-24-054507.md) | [214](/filings/0000950170-24-094014.md) | [154](/filings/0000950170-24-122324.md) | [149](/filings/0001193125-26-071592.md) | [150](/filings/0000950170-25-066990.md) | [151](/filings/0000950170-25-104058.md) | [168](/filings/0001193125-25-269594.md) | [159](/filings/0001193125-26-338055.md) | [166](/filings/0001193125-26-211991.md) | [157](/filings/0001193125-26-338055.md) |
| Total assets | $m | [3,776](/filings/0000950170-23-058224.md) | [3,790](/filings/0000950170-25-029068.md) | [3,863](/filings/0000950170-24-054507.md) | [4,050](/filings/0000950170-24-094014.md) | [4,147](/filings/0000950170-24-122324.md) | [4,151](/filings/0001193125-26-071592.md) | [4,264](/filings/0000950170-25-066990.md) | [4,423](/filings/0000950170-25-104058.md) | [4,438](/filings/0001193125-25-269594.md) | [4,388](/filings/0001193125-26-338055.md) | [4,317](/filings/0001193125-26-211991.md) | [4,257](/filings/0001193125-26-338055.md) |
| Current liabilities | $m | [174](/filings/0000950170-23-058224.md) | [210](/filings/0000950170-25-029068.md) | [157](/filings/0000950170-24-054507.md) | [192](/filings/0000950170-24-094014.md) | [221](/filings/0000950170-24-122324.md) | [219](/filings/0001193125-26-071592.md) | [186](/filings/0000950170-25-066990.md) | [214](/filings/0000950170-25-104058.md) | [224](/filings/0001193125-25-269594.md) | [188](/filings/0001193125-26-338055.md) | [181](/filings/0001193125-26-211991.md) | [204](/filings/0001193125-26-338055.md) |
| Total liabilities | $m | [3,330](/filings/0000950170-23-058224.md) | [3,426](/filings/0000950170-25-029068.md) | [3,481](/filings/0000950170-24-054507.md) | [3,648](/filings/0000950170-24-094014.md) | [3,705](/filings/0000950170-24-122324.md) | [3,686](/filings/0001193125-26-071592.md) | [3,751](/filings/0000950170-25-066990.md) | [3,916](/filings/0000950170-25-104058.md) | [4,011](/filings/0001193125-25-269594.md) | [3,950](/filings/0001193125-26-338055.md) | [3,942](/filings/0001193125-26-211991.md) | [3,869](/filings/0001193125-26-338055.md) |
| Long-term debt | $m | [3,138](/filings/0000950170-23-058224.md) | [3,199](/filings/0000950170-25-029068.md) | [3,310](/filings/0000950170-24-054507.md) | [3,443](/filings/0000950170-24-094014.md) | [3,470](/filings/0000950170-24-122324.md) | [3,449](/filings/0001193125-26-071592.md) | [3,547](/filings/0000950170-25-066990.md) | [3,687](/filings/0000950170-25-104058.md) | [3,765](/filings/0001193125-25-269594.md) | [3,740](/filings/0001193125-26-338055.md) | [3,737](/filings/0001193125-26-211991.md) | [3,643](/filings/0001193125-26-338055.md) |
| Current portion of debt | $m | [10.0](/filings/0000950170-23-058224.md) | [12.5](/filings/0000950170-25-029068.md) | [15.0](/filings/0000950170-24-054507.md) | [17.5](/filings/0000950170-24-094014.md) | [20.0](/filings/0000950170-24-122324.md) | [22.5](/filings/0001193125-26-071592.md) | [25.0](/filings/0000950170-25-066990.md) | [27.5](/filings/0000950170-25-104058.md) | [30.0](/filings/0001193125-25-269594.md) | [32.5](/filings/0001193125-26-338055.md) | [35.0](/filings/0001193125-26-211991.md) | [37.5](/filings/0001193125-26-338055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [216 d](/filings/0000950170-24-122324.md) | [248 d](/filings/0001193125-26-071592.md) | [185](/filings/0000950170-25-066990.md) | [272 d](/filings/0000950170-25-104058.md) | [225 d](/filings/0001193125-25-269594.md) | [259 d](/filings/0001193125-26-071592.md) | [202](/filings/0001193125-26-211991.md) | [277 d](/filings/0001193125-26-338055.md) | [259 d](/filings/0001193125-25-269594.md) | [246 d](/filings/0001193125-26-071592.md) | [253](/filings/0001193125-26-211991.md) | [279 d](/filings/0001193125-26-338055.md) |
| Capital expenditure | $m | [52.7 d](/filings/0000950170-24-122324.md) | [63.5 d](/filings/0001193125-26-071592.md) | [54.8](/filings/0000950170-25-066990.md) | [63.9 d](/filings/0000950170-25-104058.md) | [92.3 d](/filings/0001193125-25-269594.md) | [95.1 d](/filings/0001193125-26-071592.md) | [45.5](/filings/0001193125-26-211991.md) | [63.4 d](/filings/0001193125-26-338055.md) | [80.0 d](/filings/0001193125-25-269594.md) | [66.7 d](/filings/0001193125-26-071592.md) | [28.8](/filings/0001193125-26-211991.md) | [23.1 d](/filings/0001193125-26-338055.md) |
| Share repurchases | $m | [100 d](/filings/0000950170-24-122324.md) | [100 d](/filings/0001193125-26-071592.md) | [100](/filings/0000950170-25-066990.md) | [100 d](/filings/0000950170-25-104058.md) | [100 d](/filings/0001193125-25-269594.md) | [0.0 d](/filings/0001193125-26-071592.md) | [100](/filings/0001193125-26-211991.md) | [200 d](/filings/0001193125-26-338055.md) | [100 d](/filings/0001193125-25-269594.md) | [0.0 d](/filings/0001193125-26-071592.md) | [60.0](/filings/0001193125-26-211991.md) | [0.0 d](/filings/0001193125-26-338055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 128,350,881 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.